Variational Ai

Variational Ai, located in Vancouver, British Columbia, is a company focused on revolutionizing drug discovery through advanced AI technology. Founded in September 2019, the team comprises experienced AI/machine learning researchers and medicinal and computational chemists. By leveraging generative AI algorithms, the company collaborates closely with biopharmaceutical partners to accelerate the discovery of novel drug-like small molecules.

At Variational Ai, Enki™, an ensemble of generative algorithms, is utilized to create novel and selective lead structures in a matter of weeks. The platform is trained on a wide range of targets, with more continually added, allowing for efficient and data-driven drug discovery without the need for extensive datasets. By defining the desired properties, Enki does the heavy lifting, offering a seamless and innovative approach to molecule creation.

The company's mission is to redefine the economics of drug discovery and development by introducing cutting-edge technology to the field. Through a multidisciplinary team and strategic collaborations, Variational Ai aims to bring new therapeutics to market across various disease areas, ultimately impacting lives positively. Variational Ai is at the forefront of leveraging AI to drive advancements in the pharmaceutical industry.

Generated from the website content